Restoring expression of tumour suppressor PTEN by engineered circular RNA‐enhanced Osimertinib sensitivity in non‐small cell lung cancer
Clinical and Translational Medicine · 2024
DOI: 10.1002/ctm2.1792 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Haoran Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Oncology Institute/Research Unit of Intelligence Diagnosis and Treatment in Early Non-Small Cell Lung Cancer, Peking University People's Hos…. Hauptthemen laut MEDLINE: PTEN Phosphohydrolase, Carcinoma, Non-Small-Cell Lung, RNA, Circular, Acrylamides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Beijing Nova Program.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Thoracic Oncology Institute/Research Unit of Intelligence Diagnosis and Treatment in Early Non-Small Cell Lung Cancer, Peking University People's Hospital, Beijing, China.
- Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China.
- Institute of Advanced Clinical Medicine, Peking University, Beijing, China.
ORCID-Profile: Kezhong Chen, Mantang Qiu
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Beijing Nova Program
- Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer (Chinese Academy of Medical Sciences)
- Peking University People's Hospital Research and Development Founds
- Peking University Medicine Sailing Program for Young Scholars' Scientific & Technological Innovation
- National Key Research and Development Program of China
Zitieren
APA
Li, H., Liu, Z., Chen, S., Cai, J., Wang, P., Chen, K., & Qiu, M. (2024). Restoring expression of tumour suppressor PTEN by engineered circular RNA‐enhanced Osimertinib sensitivity in non‐small cell lung cancer. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1792
Vancouver
Li H, Liu Z, Chen S, Cai J, Wang P, Chen K, et al. Restoring expression of tumour suppressor PTEN by engineered circular RNA‐enhanced Osimertinib sensitivity in non‐small cell lung cancer. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.1792
BibTeX
@article{Li2024,
author = {Li, Haoran and Liu, Zheng and Chen, Shaoyi and Cai, Jingsheng and Wang, Peiyu and Chen, Kezhong and Qiu, Mantang},
title = {Restoring expression of tumour suppressor PTEN by engineered circular RNA‐enhanced Osimertinib sensitivity in non‐small cell lung cancer},
journal = {Clinical and Translational Medicine},
year = {2024},
doi = {10.1002/ctm2.1792}
}
EUVIMED